You are not a horse. You are not a cow. Seriously, y'all. Stop it. www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19
Big news: the FDA has FULLY approved the Pfizer Coronavirus Vaccine. Thanks to the historic Operation Warp Speed under the Trump-Pence Administration, Americans have access to three safe and effective vaccines in record time!
The Food and Drug Administration’s full authorization of the Pfizer-BioNTech vaccine today is a great milestone in our fight against this deadly pandemic. It is clear there is no safer, faster or more effective way to stop the transmission of this virus than through vaccination. pic.twitter.com/rbXWvz9bcz
The @US_FDA has fully approved the Pfizer vaccine! #COVID19 vaccines are safe, effective and free — and if you get your first shot at a City-run site, you’ll get $100. Get it done: nyc.gov/vax4nyc pic.twitter.com/YVNTw9GbvO
While Mondays approval doesn’t cover young people ages 12 to 15, they can still get the Pfizer vaccine through emergency use authorization.
No Covid vaccines have been authorized or approved for use in children under 12. Emergency use authorization for younger children is expected in the fall or winter. But several steps need to be taken first, including the completion of clinical trials.
Dr. Peter Marks, the director of the FDA’s Center for Biologics Evaluation and Research, said in a video news conference Monday that trials for vaccines for children continue and that the agency “has to wait for the company to submit the data from those trials so that we have a good safety dataset, because we certainly want to make sure that we get it right in the children ages 5 through 11 and then even in younger children after that.”
Marks said the FDA will “obviously move swiftly once those data are submitted, but first the trials have to be finished up, or at least the parts of the trials that can be submitted to us have to be finished up, and then the data needs to be submitted to us.”
Pfizer CEO Albert Bourla told NBC News’ Lester Holt on Monday that the company is running “very large studies right now” with children under 12. He said it expected that studies on children ages 5 to 11 would be completed in September and that the company could then submit the data to the FDA.
The FDA has asked for four to six months of follow-up safety data from the children’s clinical trials — compared to two months’ follow-up data required for the adult vaccine trials.
The AAP said there were 180,000 new cases of Covid-19 among children and adolescents in the week that ended Thursday.
“The clinical trials for the Covid-19 vaccine in children ages 11 years old and younger are underway, and we need to see the data from those studies before we give this vaccine to younger children,” AAP President Lee Savio Beers said in the statement. “The dose may be different for younger ages. The AAP recommends against giving the vaccine to children under 12 until authorized by the FDA.”
NBC News reported last month that emergency authorization for Covid-19 vaccines in children under 12 could come in early to midwinter, according to an FDA official. The agency hopes to then move quickly to full approval for that age group.
Read full article at NBC News